Effect of neuroleptic treatment on depressive symptoms in acute schizophrenic episodes

Psychiatry Research

Volumn 71, Issue 1, 1997, Pages 19-26

  Krakowski, Menahem ^a   Czobor, Pal ^a   Volavka, Jan ^a  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

Extrapyramidal symptoms; Neuroleptic effects; Plasma levels

Indexed keywords

BENZATROPINE; HALOPERIDOL; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELUSION; DEPRESSION; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; DEPRESSION; FEMALE; HALOPERIDOL; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA;

EID: 0030741715     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(97)03076-X     Document Type: Article

References (27)

1. Andreasen, N.C., Olsen, S., 1982. Negative v positive schizophrenia. Definition and validation. Arch. Gen. Psychiatry 39, 789-794.
2. Ayd, F.J., 1975. The depot fluphenazines: a reappraisal after 10 years' clinical experience. Am. J. Psychiatry 132, 491-500.
3. Azorin, J.M., 1995. Long-term treatment of mood disorders in schizophrenia. Acta. Psychiatr. Scand. Suppl. 388:20-23.
4. Bandelow, B., Muller, P., Frick, U., Gaebel, W., Linden, M., Muller-Spahn, F., Pietzcker, A., Tegeler, J., 1992. Depressive syndromes in schizophrenic patients under neuroleptic therapy. Eur. Arch. Psychiatry Clin. Neurosci. 241, 291-295.
5. Bermanzohn, P.C., Siris, S.G., 1992. Akinesia: a syndrome common to parkinsonism, retarded depression, and negative symptoms of schizophrenia. Compr. Psychiatry 33, 221-232.
6. Bleuler, E., 1924. Textbook of Psychiatry. The Macmillan Co, New York.
7. Chouinard, G., Jones, B.D., 1978. Schizophrenia as dopamine-deficiency disease. Lancet 2, 99-100.
8. Craig, T.J., Richardson, M.A., Pass, R., Bregman, Z., 1985. Measurement of mood and affect in schizophrenic inpatients. Am. J. Psychiatry 142, 1272-1277.
9. Czobor, P., Bitter, I., Volavka, J., 1991. Relationship between the Brief Psychiatric Rating Scale and the Scale for the Assessment of Negative Symptoms: a study of their correlation and redundancy. Psychiatry Res. 36, 129-139.
10. Donlon, P.T., Rada, R.T., Arora, K.K., 1976. Depression and the reintegration phase of acute schizophrenia. Am. J. Psychiatry 133, 1265-1268.
11. Endicott, J., Spitzer, R.L., 1978. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch. Gen. Psychiatry 35, 773-782.
12. Galdi, J., 1983. The causality of depression in schizophrenia. Br. J. Psychiatry 142, 621-624.
13. Galdi, J., Rieder, R.O., Silber, D., Bonato, R.R., 1981. Genetic factors in the response to neuroleptics in schizophrenia: a psychopharmacogenetic study. Psychol. Med. 11, 713-728.
14. Guy, W., 1976. Assessment Manual for Psychopharmacology. Revised. National Institute of Mental Health, Rockville, MD.
15. Harrow, M., Yonan, C.A., Sands, J.R., Marengo, J., 1994. Depression in schizophrenia: are neuroleptics, akinesia, or anhedonia involved? Schizophr. Bull. 20, 327-338.
16. Hirsch, S.R., 1982. Depression 'revealed' in schizophrenia. Br. J. Psychiatry. 140, 421-423.
17. Johnson, D.A., 1981. Studies of depressive symptoms in schizophrenia. Br. J. Psychiatry 139, 89-101.
18. Knights, A., Hirsch, S.R., 1981. 'Revealed' depression and drug treatment for schizophrenia. Arch. Gen. Psychiatry 38, 806-811.
19. Norman, R.M., Malla, A.K., 1994. Correlations over time between dysphoric mood and symptomatology in schizophrenia. Compr. Psychiatry 35, 34-38.
20. Overall, J.E., Gorham, D.R., 1962. The Brief Psychiatric Rating Scale. Psychol. Rep. 10, 799-812.
21. Planansky, K., Johnston, R., 1978. Depressive syndrome in schizophrenia. Acta. Psychiatr. Scand. 57, 207-218.
22. Rhoades, H.M., Overall, J.E., 1983. The Hamilton depression scale: factor scoring and profile classification. Psychol. Pharmacol. Bull. 19, 91-96.
23. Simpson, G.M., Angus, J.W.S., 1970. A rating scale for extrapyramidal side effects. Acta. Psychiatr. Scand. 212 (suppl), 9-11.
24. Spitzer, R.L., Endicott, J., Robins, E., 1978. Research diagnostic criteria: rationale and reliability. Arch. Gen. Psychiatry 35, 773-782.
25. Thiemann, S., Csernansky, J.G., Berger, P.A., 1987. Rating scales in research: the case of negative symptoms. Psychiatry Res. 20, 47-55.
26. Van Putten, T., May, P.R.A., 1978. 'Akinetic depression' in schizophrenia. Arch. Gen. Psychiatry 35, 1101-1107.
27. Volavka, J., Cooper, T., Czobor, P., Bitter, I., Meisner, M., Laska, E., Gastanaga, P., Krakowski M., Chou, J.C., Crowner, M., 1992. Haloperidol blood levels and clinical effects. Arch. Gen. Psychiatry 49, 354-361.